NCT07569341已完成不适用
Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases
University Hospital, Linkoeping1 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2021年11月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 116
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
The aim of this study is to validate a proposed classification system regarding overall survival as well as a comparison with patients with liver metastases and extrahepatic metastasis of colorectal cancer. The study also aims to identify the proportion of patients in each group, the proportion of patients converted from 4c to 4b and to compare survival to the patients only treated with chemotherapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Colorectal liver metastasis.
- •Discussed at a multidisciplinary tumor board
排除标准
- •Age less than 18 years.
- •Previous cancer in the gastrointestinal tract
- •Ongoing oncological treatment for cancers other than gastrointestinal cancers
结局指标
主要结局
Overall survival
时间窗: 3 years
次要结局
未报告次要终点
研究者
Per Sandström
Professor
University Hospital, Linkoeping
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label StudyNCT07373899Cancer Institute and Hospital, Chinese Academy of Medical Sciences354
Enrolling By Invitation
不适用
Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic TherapyHepatocellular CarcinomaNCT07290764Fujian Provincial Hospital729
尚未招募
4 期
Success Rate of Two Different Antibiotic Treatments for Saving Decayed Baby Teeth: A Triple-Blinded, Randomized StudyCTRI/2025/02/081024PMS College of Dental Science and Research158
招募中
2 期
Phase II multicentric study: efficacy evaluation of neo-adjuvant treatment associated with maintenance therapy by anti-PD1 immunotherapy on disease-free-survival (DFS) in patients with resectable mucosal melanoma2024-513027-16-00Institut Gustave Roussy60
招募中
3 期
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon CancerNCT07412613Akeso386